{"id":"https://openalex.org/W2058733704","doi":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","title":"Tripstar: A Comprehensive Patient\u2010Based Approach to Compare Triptans","display_name":"Tripstar: A Comprehensive Patient\u2010Based Approach to Compare Triptans","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2058733704","doi":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","mag":"2058733704","pmid":"https://pubmed.ncbi.nlm.nih.gov/11966860"},"language":"en","primary_location":{"id":"doi:10.1046/j.1526-4610.2002.0420s1018.x","doi":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","pdf_url":null,"source":{"id":"https://openalex.org/S96331937","display_name":"Headache The Journal of Head and Face Pain","issn_l":"0017-8748","issn":["0017-8748","1526-4610"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Headache: The Journal of Head and Face Pain","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039941295","display_name":"Michel Dominique Ferrari","orcid":"https://orcid.org/0000-0001-9691-9449","observed_orcids":["https://orcid.org/0000-0001-9691-9449"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Michel D. Ferrari","raw_affiliation_strings":["Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands","From the Department of Neurology, Leiden University Medical Centre, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"From the Department of Neurology, Leiden University Medical Centre, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039941295"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.4955,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.81275283,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"42","issue":"s1","first_page":"18","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triptans","display_name":"triptans","score":0.8880000114440918},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.7450000047683716},{"id":"https://openalex.org/keywords/sumatriptan","display_name":"sumatriptan","score":0.8370000123977661},{"id":"https://openalex.org/keywords/almotriptan","display_name":"almotriptan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/rizatriptan","display_name":"rizatriptan","score":1.0},{"id":"https://openalex.org/keywords/eletriptan","display_name":"eletriptan","score":1.0},{"id":"https://openalex.org/keywords/drug-comparison","display_name":"drug comparison","score":0.7360000014305115},{"id":"https://openalex.org/keywords/treatment-characteristics","display_name":"treatment characteristics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7900000214576721},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-acceptability","display_name":"drug acceptability","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2777119127","wikidata":"https://www.wikidata.org/wiki/Q423866","display_name":"Triptans","level":3,"score":0.9678892493247986},{"id":"https://openalex.org/C2777030092","wikidata":"https://www.wikidata.org/wiki/Q212171","display_name":"Rizatriptan","level":5,"score":0.8717341423034668},{"id":"https://openalex.org/C2778871607","wikidata":"https://www.wikidata.org/wiki/Q416978","display_name":"Sumatriptan","level":4,"score":0.8600916862487793},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7708622217178345},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.757900595664978},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.6851007342338562},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4586141109466553},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.457265704870224},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.394504576921463},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35458409786224365},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23359093070030212},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21120768785476685},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09723755717277527},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014363","descriptor_name":"Tryptamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014363","descriptor_name":"Tryptamines","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D014363","descriptor_name":"Tryptamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015201","descriptor_name":"Meta-Analysis as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018170","descriptor_name":"Sumatriptan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018170","descriptor_name":"Sumatriptan","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018170","descriptor_name":"Sumatriptan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1526-4610.2002.0420s1018.x","doi":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1526-4610.2002.0420s1018.x","pdf_url":null,"source":{"id":"https://openalex.org/S96331937","display_name":"Headache The Journal of Head and Face Pain","issn_l":"0017-8748","issn":["0017-8748","1526-4610"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Headache: The Journal of Head and Face Pain","raw_type":"journal-article"},{"id":"pmid:11966860","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11966860","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Headache","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/10","score":0.7300000190734863,"display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W43117497","https://openalex.org/W48014111","https://openalex.org/W58525860","https://openalex.org/W124053138","https://openalex.org/W1964647610","https://openalex.org/W2002377344","https://openalex.org/W2072266462","https://openalex.org/W2072888650","https://openalex.org/W2078764239","https://openalex.org/W2114413295","https://openalex.org/W2126194551","https://openalex.org/W2149133494","https://openalex.org/W4230891577","https://openalex.org/W4237055384"],"related_works":["https://openalex.org/W2150385130","https://openalex.org/W2147033083","https://openalex.org/W2434514132","https://openalex.org/W2095387767","https://openalex.org/W2003573954","https://openalex.org/W2091662781","https://openalex.org/W2047700866","https://openalex.org/W1965110035","https://openalex.org/W58525860","https://openalex.org/W1964585649"],"abstract_inverted_index":{"Several":[0],"second-generation":[1],"triptans":[2,130],"have":[3],"been":[4],"introduced":[5],"that":[6,56,128,158,214],"differ":[7],"in":[8],"their":[9],"pharmacologic":[10],"profiles":[11],"relative":[12,143,218],"to":[13,17,27,70,131,163,175,197],"each":[14],"other":[15],"and":[16,63,89,108,170],"sumatriptan.":[18],"As":[19],"therapeutic":[20],"options":[21],"multiply,":[22],"clinicians":[23],"must":[24],"be":[25,100],"able":[26],"distinguish":[28],"among":[29],"these":[30],"compounds.":[31],"Recently,":[32],"a":[33,111,132,164,188,221],"meta-analysis":[34,136],"was":[35],"conducted":[36],"on":[37,75],"data":[38,137],"from":[39],"53":[40],"double-blind,":[41],"randomized,":[42],"placebo-":[43],"or":[44],"active-controlled":[45],"trials":[46],"involving":[47],"over":[48],"24,000":[49],"patients":[50,107],"receiving":[51],"oral":[52],"triptans.":[53],"Results":[54],"indicated":[55,157],"almotriptan":[57,191],"12.5":[58,192],"mg,":[59,62],"rizatriptan":[60],"10":[61],"eletriptan":[64],"80":[65],"mg":[66,73,193],"are":[67,92,212],"generally":[68],"superior":[69],"sumatriptan":[71,159],"100":[72],"based":[74],"individual":[76,103],"treatment":[77,114,148],"attributes,":[78],"such":[79],"as":[80,95,187],"pain":[81,84],"relief,":[82],"sustained":[83],"freedom,":[85],"consistency":[86],"of":[87,113,141,145,153,184,202,208,220,224],"response,":[88],"tolerability.":[90,205],"Meta-analyses":[91],"limited,":[93],"however,":[94],"the":[96,142,154,198,209,217],"analysis":[97],"can":[98],"only":[99],"performed":[101],"for":[102,167],"end":[104],"points,":[105],"whereas":[106],"prescribers":[109],"balance":[110],"variety":[112],"attributes":[115],"when":[116],"assessing":[117],"drug":[118],"acceptability.":[119],"A":[120],"flexible":[121],"overall":[122],"scoring":[123],"system":[124],"(\"Tripstar\")":[125],"is":[126,160,194],"proposed":[127],"compares":[129],"hypothetical":[133,165],"\"ideal\"":[134],"using":[135],"combined":[138],"with":[139],"ratings":[140],"importance":[144,219],"clinically":[146],"relevant":[147],"criteria.":[149],"An":[150],"informal":[151],"test":[152],"Tripstar":[155,210],"model":[156,211],"most":[161,195],"similar":[162,196],"ideal":[166],"both":[168],"mild":[169],"severe":[171],"migraine,":[172],"primarily":[173],"due":[174],"its":[176,203],"high":[177],"worldwide":[178,185],"clinical":[179],"exposure.":[180],"However,":[181],"after":[182],"exclusion":[183],"exposure":[186],"contributing":[189],"factor,":[190],"ideal,":[199],"principally":[200],"because":[201],"good":[204],"Further":[206],"tests":[207],"planned":[213],"will":[215],"gauge":[216],"broader":[222],"range":[223],"attributes.":[225]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}